Rank #1: Irritable bowel syndrome: The Lancet Gastroenterology & Hepatology: Feb 2017
Magnus Simrén comprehensively reviews treatments and therapies for irritable bowel syndrome.
Jan 12 2017
Rank #2: Treating faecal incontinence in women
Dr Eric Jelovsek discusses new research into the treatment of this important and often overlooked condition.
Jul 17 2019
Rank #3: Global burden of pancreatic cancer and colorectal cancer
Mohsen Naghavi describes the key findings from two new Global Burden of Disease studies investigating the global burden of pancreatic cancer and colorectal cancer.
Nov 04 2019
Rank #4: Inflammatory bowel disease: The Lancet Gastroenterology & Hepatology: December issue
Gil Kaplan discusses the rise of IBD in countries that don't have a history of the disease.
Nov 09 2016
Rank #5: A new drug for short bowel syndrome
Dr Rahim Naimi discusses the results of a phase 2 trial of glepaglutide to treat short bowel syndrome.
Apr 05 2019
Rank #6: Liver fibrosis screening: The Lancet Gastroenterology & Hepatology: October 12, 2016
Pere Ginès from the Liver Unit at the Hospital Clinic in Barcelona, Spain, discusses a Viewpoint for liver fibrosis screening in the general population.
Oct 13 2016
Rank #7: Acute hepatitis C
Bart Rijnders discusses his recent work on the treatment of people with acute hepatitis C.
Mar 08 2019
Rank #8: Epidemiology of chronic liver disease
Jennifer Flemming talks with The Lancet Gastroenterology & Hepatology about recent developments in the field of chronic liver disease.
Feb 08 2019
Rank #9: Colorectal cancer in sub-Saharan Africa: The Lancet Gastroenterology & Hepatology: April 5, 2017
Leo Katsidzira talks about the epidemiology of colorectal cancer in sub-Saharan Africa.
Apr 06 2017
Rank #10: Whole-body MRI: the STREAMLINE trials
Stuart Taylor discusses the results of the STREAMLINE trials, which assessed the use of whole-body MRI to stage colorectal and lung cancers.
May 11 2019
Rank #11: Paediatric inflammatory bowel disease
Viktor Wintzell joins The Lancet Gastroenterology & Hepatology to discuss the risk of serious infection after use of tumour necrosis factor-α inhibitors in children with inflammatory bowel disease.
Sep 12 2019
Rank #12: Pancreatic cancer treatment
Michele Reni speaks with The Lancet Gastroenterology & Hepatology about the PAXG regimen for treatment of pancreatic cancer.
Sep 06 2018
Rank #13: Viral hepatitis in children & adolescents
Philippa Easterbrook discusses a series of two Review articles on viral hepatitis in children and adolescents.
May 23 2019
Rank #14: Faecal microbiota transplantation in IBS
Dr Olga Aroniaidis discusses the results of a newly published trial of FMT to treat IBS.
Jul 30 2019
Rank #15: DAA treatment for hepatitis C among people who inject drugs
Behzad Hajarizadeh joins The Lancet Gastroenterology and Hepatology to discuss his work with direct-acting antiviral treatments for hepatitis C among people inject drugs.
Oct 25 2018
Rank #16: Barrett's oesophagus: The Lancet Gastroenterology & Hepatology: Jan 2017
Rebecca Fitzgerald discusses her paper on risk stratification for patients with Barrett's oesophagus.
Dec 10 2016
Rank #17: Treatment of an appendix mass in children: The Lancet Gastroenterology & Hepatology: March 8, 2017
As part of The Lancet Gastroenterology & Hepatology’s April issue, Nigel Hall discusses the CHINA trial of observation versus interval appendicectomy for children with an appendix mass.
Mar 08 2017
Rank #18: Viral hepatitis in migrant populations
Graham Foster speaks with The Lancet Gastroenterology & Hepatology about his recent work on incentivising and supporting primary-care physicians to increase hepatitis screenings of migrant populations.
Dec 07 2018
Rank #19: Treatment and reinfection risk for hepatitis C treatment: The Lancet Gastroenterology & Hepatology: February 8, 2017
Naveed Janjua discusses a study looking at the risk factors associated with hepatitis C reinfection and means to prevent it.
Feb 09 2017
Rank #20: Transplanting hepatitis C-infected hearts
Prof Raymond Chung discusses new research in transplantation of HCV-infected hearts.
Aug 28 2019